# EMMAUS LIFE SCIENCES, INC.: Form D filings

EMMAUS LIFE SCIENCES, INC., a pharmaceuticals company in Torrance, CA, filed 9 Form D notices with the SEC between 2011 and 2019. The latest, on April 1, 2019, reports $2.6 million sold of an offering with no set size to 7 investors.

Find out what EMMAUS LIFE SCIENCES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20EMMAUS%20LIFE%20SCIENCES%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=EMMAUS%20LIFE%20SCIENCES%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Femmaus-life-sciences-inc-1420031)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20EMMAUS%20LIFE%20SCIENCES%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=EMMAUS%20LIFE%20SCIENCES%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Femmaus-life-sciences-inc-1420031)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 21250 HAWTHORNE BLVD., SUITE 800, Torrance, CA, 90503
- Phone: (310) 214-0065
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $5,000,001 - $25,000,000
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1420031

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 1, 2019 | New notice | Indefinite | $2,585,000 | Indefinite | 7 | Feb 12, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000125085319000059/0001250853-19-000059-index.htm) |
| Nov 1, 2018 | New notice | $12,200,000 | $12,200,000 | $0 | 18 | Oct 22, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000125085318000136/0001250853-18-000136-index.htm) |
| Oct 14, 2016 | New notice | $20,000,000 | $20,000,000 | $0 | 2 | Sep 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000110465916150324/0001104659-16-150324-index.htm) |
| Jan 20, 2016 | New notice | $40,000,000 | $1,700,000 | $38,300,000 | 0 | Jan 13, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000110465916090676/0001104659-16-090676-index.htm) |
| Oct 2, 2013 | Amendment | $7,551,253 | $7,551,253 | $0 | 36 | Sep 11, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000138713113003661/0001387131-13-003661-index.htm) |
| Sep 24, 2013 | New notice | $7,551,253 | $7,551,253 | $0 | 36 | Sep 11, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000138713113003506/0001387131-13-003506-index.htm) |
| Oct 18, 2011 | New notice | $3,715,079 | $3,715,079 | $0 | 13 | Jun 29, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000144856511000021/0001448565-11-000021-index.htm) |
| Sep 26, 2011 | New notice | Indefinite | $0 | Indefinite | 318 | May 3, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000144856511000020/0001448565-11-000020-index.htm) |
| Apr 4, 2011 | New notice | $1,200,000 | $1,013,500 | $186,500 | 61 | Mar 25, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1420031/000148813811000001/0001488138-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Yutaka Niihara | Executive Officer, Director |  |
| Kurt Kruger | Executive Officer |  |
| Willis Lee | Executive Officer, Director |  |
| Lan Tran | Executive Officer |  |
| Yasushi Nagasaki | Executive Officer |  |
| Robert Dickey | Director |  |
| Masaharu Osato | Director |  |
| Wei Peu Zen | Director |  |
| Ian Zwicker | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Apr 1, 2019](https://specstream.ai/data/form-d/week/2019-04-01) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what EMMAUS LIFE SCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).